COVID-19: all 7,775 studies

Page 60 of 78. Open to participants first (482), then studies with results posted, then the rest; newest registration first within each.

• CorONa Virus edoxabaN ColchicinE (CONVINCE) COVID-19TerminatedNCT04516941Phase 3
• Study of SARS-CoV2 Virus (COVID-19) Seroprevalence Among Lyon-Bron Military Health Schools PersonnelCompletedNCT04516928
• IMU-838 and Oseltamivir in the Treatment of COVID-19CompletedNCT04516915Phase 2
• Eltrombopag Plus rhTPO Versus Eltrombopag for ITP During the COVID-19 Pandemic (ELABORATE-19)Status unknownNCT04516837Phase 2
• Experience of Orthopaedic and Spine Center Pakistan During COVID-19CompletedNCT04516824
• Therapeutic Use of Convalescent Plasma in the Treatment of Patients With Moderate to Severe COVID-19TerminatedNCT04516811Phase 3
• Effect of Tele-consultation in Addition With Psychiatric Follow-up During COVID-19 in Women Who Have Medical History of Post-partum DepressionStatus unknownNCT04516668
• A Study of AK119 (Anti-CD73 Antibody), a Treatment for COVID-19, in Healthy SubjectsCompletedNCT04516564Phase 1
• Assessment of SARS-CoV-2 Seroprevalence in DetentionCompletedNCT04516512Not applicable
• Coronavirus Studied by Metagenomics in ARDS COVID-19 PatientsStatus unknownNCT04516486
• Home Management of Adult Egyptian Mild COVID-19 CasesStatus unknownNCT04515199
• Perinatal Outcomes and Hematologic Parameters in COVID-19 PregnanciesCompletedNCT04515108
• Assessment of the Prevalence and the Impact of the COVID-19 Epidemic in the French Flight Crew in 2020CompletedNCT04514874
• Neuromodulation With Percutaneous Electrical Nerve Field Stimulation for Adults With COVID-19CompletedNCT04514627Not applicable
• Safety and Efficacy of Anti-SARS-CoV-2 Equine Antibody F(ab')2 Fragments (INOSARS) for Adult Patients With Mild COVID-19CompletedNCT04514302Phase 1
• Cross Sectional CFAR HIV/COVID-19 StudyCompletedNCT04514016
• The Corona and COVID-19 Study in Telemark and AgderActive, not recruitingNCT04514003
• Novel Point-of-Care Diagnostic Test for SARS-CoV-2 (COVID-19)Status unknownNCT04513990Not applicable
• Impact of COVID-19 on the Benefit of Cardiac RehabilitationWithdrawnNCT04513964
• PsoVac: Educational Needs re Vaccines for Biologic Patients With PsoriasisCompletedNCT04513847
• Evaluation of the Impact of Lock Down and End of Lock Down on the Management of Patients With Inflammatory and Dysimmune Diseases Followed in the Context of IMMINeNT FHU and COVID-19CompletedNCT04513561
• Allocetra-OTS in COVID-19Status unknownNCT04513470Phase 1
• Valproate Alone or in Combination With Quetiapine for Severe COVID-19 Pneumonia With Agitated DeliriumWithdrawnNCT04513314Phase 4
• Reliability of Standardized Protocol of Ultrasound of the Lungs in Prediction of Severity of Covid-19 InfectionCompletedNCT04513210
• Randomized Clinical Trial of Intranasal Dexamethasone as an Adjuvant in Patients With COVID-19CompletedNCT04513184Phase 2
• Parental Attitude Toward Children Dental Treatment During COVID-19 PandemicCompletedNCT04512300
• CT Abnormalities Evocative of Lung Infection Are Associated With Lower 18F-FDG Uptake in Confirmed COVID-19 PatientsCompletedNCT04512118
• FREEDOM COVID-19 Anticoagulation StrategyCompletedNCT04512079Phase 4
• Prolectin-M in COVID-19 Patients Having Mild to Moderate Symptoms Not Requiring Oxygen Support.CompletedNCT04512027Not applicable
• Feasibility, of Tele-rehabilitation Following COVID-19Active, not recruitingNCT04511962
• COVID-19: Epidemiological Study of the Spread of SARS-CoV-2 in the Household of a Person Who Has Had a COVID-19 DiseaseCompletedNCT04511949Not applicable
• Nebulised Heparin to Reduce COVID-19 Induced Acute Lung InjuryCompletedNCT04511923Phase 1/2
• Psychological Impact of COVID-19 Outbreak on CaregiversCompletedNCT04511780
• COVID-19 in Immunosuppressed ChildrenStatus unknownNCT04511429
• Telmisartan in Respiratory Failure Due to COVID-19CompletedNCT04510662Phase 2
• Host Response Mediators in Coronavirus (COVID-19) InfectionStatus unknownNCT04510623
• Canakinumab in Patients With COVID-19 and Type 2 DiabetesCompletedNCT04510493Phase 3
• Mental Health Consequences of COVID19 Infection in the French RMD CohortTerminatedNCT04510467
• Evaluation of a ddPCR Technology for the SARS-CoV-2 Detection in Symptomatic Patients With Suspicion of COVID-19CompletedNCT04510454Not applicable
• Artificial Intelligence-assisted Diagnosis and Prognostication in COVID-19 Using ElectrocardiogramsStatus unknownNCT04510441
• Phase I/II Trial of Povidone-iodine (PVP-I) Nasal Swab For Preventing COVID-19 Spread in Healthy SubjectsStatus unknownNCT04510402Phase 1/2
• Ivermectin Nasal Spray for COVID19 PatientsStatus unknownNCT04510233Phase 2
• Characterizing the Immune Response and Neuronal Damage in COVID-19CompletedNCT04510012
• Bicalutamide to Block TMPRSS2 in Males With COVID-19 InfectionWithdrawnNCT04509999Phase 3
• Higher vs. Lower Doses of Dexamethasone for COVID-19 and Severe HypoxiaCompletedNCT04509973Phase 3
• Dysphagia Management During COVID-19 PandemicCompletedNCT04509752
• Canine COVID-19 DetectionStatus unknownNCT04509713
• The McGill RAAS-COVID-19 TrialCompletedNCT04508985Not applicable
• The VOICE-COVID-19CompletedNCT04508972
• The McMaster Multi-Regional COVID-19 Hospital Case RegistryStatus unknownNCT04508959
• Comparison of Extra Vascular Lung Water Index in Covid-19 ARDS and "Typical"ARDS PatientsWithdrawnNCT04508933
• COVID SAFE: COVID-19 Screening Assessment for ExposureCompletedNCT04508777
• Long-term Outcomes in Patients With COVID-19Status unknownNCT04508712
• Effect of the Use of Anticoagulant Therapy During Hospitalization and Discharge in Patients With COVID-19 InfectionStatus unknownNCT04508439Not applicable
• Efficacy, Safety and Immunogenicity Study of SARS-CoV-2 Inactivated VaccineCompletedNCT04508075Phase 3
• Comparison Between Positive and Negative COVID-19 PneumoniaCompletedNCT04507893
• Eosinophil and Anticoagulation in COVID-19 PatientsCompletedNCT04507282
• COVID-19 Associated Coagulopathy in EgyptCompletedNCT04507230
• Burden for STaff Working in the NHSActive, not recruitingNCT04506632
• COVID EHR COHORT at the University of WisconsinCompletedNCT04506528
• Psychological Impact of COVID-19 Pandemic in Healthcare WorkersCompletedNCT04506515
• COVID-19 SAFE EnrollmentCompletedNCT04506268Not applicable
• Genetic Mechanisms Underlying SARS-CoV-2 Infection and the Impact of COVID-19 on Cognitive FunctionStatus unknownNCT04506229
• Clinical, Immunological, Genomic, Virological and Bioethical Actors of COVID-19Status unknownNCT04505709
• Follow-up of Respiratory Sequelae of Hospitalized Patients With COVID-19CompletedNCT04505631
• Study of a Possible Respiratory Degradation Prognosis Caused by Biomarkers in Severe Forms of COVID-19 PneumoniaTerminatedNCT04505605
• Burnout and Distress preventiOn With caNnabidiol in Front-line Health Care workerS deAling wIth COVID-19CompletedNCT04504877Phase 2/3
• Bucillamine in Treatment of Patients With COVID-19TerminatedNCT04504734Phase 3
• Role of Famotidine in the Clinical Improvement of COVID-19 Patients.CompletedNCT04504240Phase 3
• Nutritional Assessment of Hospitalized Patients With COVID-19CompletedNCT04503525
• COVID-19 Seroprevalence Study in ITM StaffCompletedNCT04503447
• Patients' Experiences in a Medicalized Hotel for COVID-19 Acute Care SupportCompletedNCT04503434
• Efficacy of Vitamin D Treatment in Pediatric Patients Hospitalized by COVID-19CompletedNCT04502667Phase 3
• Add on to Azythromycine, Phytomedicine and/or Antimalarial Drug vs Hydroxychloroquine in Uncomplicated COVID-19 PatientsStatus unknownNCT04502342Phase 2
• Treatment of COVID-19 With Opaganib in Patients With Pneumonia Requiring OxygenWithdrawnNCT04502069Phase 1/2
• Short-term Impact of COVID-19 Lockdown on Metabolic Control of Type 2 DiabetesCompletedNCT04501991
• ACTIV-3: Therapeutics for Inpatients With COVID-19CompletedNCT04501978Phase 3
• Phytomedicines Versus Hydroxychloroquine as an Add on Therapy to Azythromycin in Asymptomatic Covid-19 PatientsStatus unknownNCT04501965Phase 2
• One-year Cardiac Follow-up of Patients With COVID-19 PneumoniaCompletedNCT04501822
• A Trial of NT-I7 in COVID-19 (SPESELPIS)TerminatedNCT04501796Phase 1
• Study of Efficacy and Safety of TL-FVP-t vs. SOC in Patients With Mild to Moderate COVID-19CompletedNCT04501783Phase 3
• Western Kenya Integrated COVID-19 ResponseStatus unknownNCT04501458Not applicable
• Cardiac Rehabilitation and Ongoing Physical Activity During COVID-19CompletedNCT04501432
• Mental Health Status and Related Factors Among Physical Medicine & Rehabilitation Physicians in the Covid-19 PandemicStatus unknownNCT04500652
• Over-the-counter Medications & COVID-19CompletedNCT04500639
• Hyperbaric Versus Normobaric Oxygen Therapy for COVID-19 PatientsStatus unknownNCT04500626Phase 2/3
• Well-Being and Health-Related Quality of Life in Cancer Patients and Survivors During the COVID-19 PandemicActive, not recruitingNCT04500600
• Charité Trial of Cenicriviroc (CVC) Treatment for COVID-19 PatientsTerminatedNCT04500418Phase 2
• GERAS Frailty Rehabilitation at Home During COVID-19CompletedNCT04500366Not applicable
• To Evaluate Safety and Efficacy of EC-18 in COVID-19 Infection to PneumoniaCompletedNCT04500132Phase 2
• Intravenous Immunoglobulin (IVIG, Bioven) Efficacy Assess for COVID-19 / SARS-CoV-2 Severe Pneumonia Complex TreatmentCompletedNCT04500067Phase 3
• FLARE: Favipiravir +/- Lopinavir: A RCT of Early AntiviralsCompletedNCT04499677Phase 2
• Tomographic Findings in COVID-19 and Influenza H1N1Status unknownNCT04499378
• Dexamethasone Vs Methylprednisolone for the Treatment of Patients With ARDS Caused by COVID-19Status unknownNCT04499313Phase 3
• Elderly Patients and COVID-19 Infection: a Cohort of Fifty Patients Over Ninety Years of AgeCompletedNCT04499300
• Mask Usage and Exercise During the COVİD-19 PandemicCompletedNCT04498546
• Psychosocial Outcomes in Families of COVID-19 ICU PatientsCompletedNCT04498507
• A Study on Prevalence, Protection and Recovery From COVID-19 in Seasoned Yoga Practitioners in Comparison to Age and Gender Matched ControlsCompletedNCT04498442Not applicable
• Evaluating the Effect of NT-I7, a Long Acting Interleukin-7, to Increase Lymphocyte Counts and Enhance Immune Clearance of SARS-CoV-2 (COVID-19)WithdrawnNCT04498325Phase 1
• Stress Echocardiography in Patients Recovery From Mild COVID-19 IllnessStatus unknownNCT04498299

← COVID-19 overview